Literature DB >> 2952721

Inhibition of suppressor T lymphocytes (Ts) by cimetidine.

D M Sahasrabudhe, C S McCune, R W O'Donnell, E C Henshaw.   

Abstract

Cyclophosphamide (CY) is the most extensively studied inhibitor of suppressor T lymphocyte (Ts) function. However, repeated administration of CY can abrogate sensitization. Therefore, we were interested in identifying noncytotoxic inhibitors of Ts function as adjuncts in the immunotherapy of Ts-inducing murine tumors. The effect of cimetidine (a histamine type 2 receptor antagonist) and diphenhydramine (a histamine type 1 receptor antagonist) on the Ts mediating tolerance to 2,4-dinitrofluorobenzene was studied. We report our data regarding the specific inhibition of Ts by cimetidine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952721

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Immunomodulating effects of T-44 in comparison to HWA 486.

Authors:  K Schmidt; H Bekemeier; J Giessler; H Pilopp
Journal:  Agents Actions       Date:  1991-01

Review 2.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate.

Authors:  N Lahat; B Alexander; D R Levin; B Moskovitz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Possible involvement of adenosine 3':5'-cyclic monophosphate and extracellular calcium ions in histamine stimulation of interleukin-1 release from macrophage-like P388D1 cells.

Authors:  H Okamoto; C Oh; K Nakano
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

5.  Synergistic antitumor activity of interleukin-2 and cimetidine against syngeneic murine tumor.

Authors:  I Nakajima; T M Chu
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 6.  Histamine2 (H2)-receptor antagonists in the treatment of urticaria.

Authors:  T C Theoharides
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

7.  Repurposing cimetidine for cholangiocarcinoma: Antitumor effects in vitro and in vivo.

Authors:  Paweena Dana; Kulthida Vaeteewoottacharn; Ryusho Kariya; Kouki Matsuda; Sopit Wongkham; Seiji Okada
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

Review 8.  How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.

Authors:  Anthony T Reder; Xuan Feng
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

9.  Cimetidine as modulator of the cell-mediated immune response in vivo using the tuberculin skin test as parameter.

Authors:  J R Snyman; E C Meyer; H S Schoeman
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

10.  Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.

Authors:  J Limpens; R J Scheper
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.